• Company News: Moderna (MRNA) Q1 revenues miss analysts’ expectations

Notícias do Mercado

6 maio 2021

Company News: Moderna (MRNA) Q1 revenues miss analysts’ expectations

Moderna (MRNA) reported Q1 FY 2021 earnings of $2.84 per share (versus -$0.35 per share in Q1 FY 2020), beating analysts’ consensus estimate of $2.47 per share.

The company’s quarterly revenues amounted to $1.937 bln, missing analysts’ consensus estimate of $2.480 bln.

MRNA fell to $148.97 (-8.52%) in pre-market trading.

O foco de mercado
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer
Abrir Conta Demo e Página Pessoal
Compreendo e aceito a Política de Privacidade e concordo que os meus dados sejam processados pela TeleTrade e usados para os seguintes efeitos: